The Scientist

» drug development, culture and ecology

Most Recent

image: Feds Demand More Clinical Trial Reporting

Feds Demand More Clinical Trial Reporting

By | September 19, 2016

Expanded US Health and Human Services rules will require the results of more human studies to be made public.

1 Comment

image: Allergan Set to Buy Vitae

Allergan Set to Buy Vitae

By | September 16, 2016

The Irish drugmaker has made a $639 million dollar offer to buy the US-based biopharma.

0 Comments

image: Zika Update

Zika Update

By | September 7, 2016

Virus’s genome to aid in diagnoses; bees caught in crossfire of mosquito sprays; Zika spreads in Asia; US Congress revisits Zika funding

1 Comment

image: This is Your Brain on Art

This is Your Brain on Art

By | September 1, 2016

Nobel Laureate Eric Kandel talks about how our brains perceive and understand works of art.

1 Comment

image: A Tribe of Hornbill Hunters Turns to Conservation

A Tribe of Hornbill Hunters Turns to Conservation

By | September 1, 2016

An indigenous community in northeastern India is a crucial part of the effort to save these majestic forest birds from extinction.

1 Comment

In Chapter 13, “Why Is Reductionism Successful in Art?” author Eric Kandel explores what about abstract art challenges the human brain.

1 Comment

image: How Art Can Inform Brain Science, and Vice Versa

How Art Can Inform Brain Science, and Vice Versa

By | September 1, 2016

Reductionism may be the key to bridging the gap between the humanities and the sciences.

0 Comments

image: Notable Science Quotes

Notable Science Quotes

By | September 1, 2016

Sensory discoveries, open-access publishing, and candidates on climate changes

1 Comment

image: The Challenges of Rare-Disease Research

The Challenges of Rare-Disease Research

By | September 1, 2016

With few resources and hesitant investors, basic scientists must rely on clinicians, patient advocates, and their own keen eye for biological connections.

0 Comments

image: Popular Tumor Cell Line Contaminated

Popular Tumor Cell Line Contaminated

By | August 31, 2016

A commercially available glioblastoma cell line appears to be from a different source than its stated origins.

0 Comments

Popular Now

  1. Opinion: Why I Published in a Predatory Journal
    News & Opinion Opinion: Why I Published in a Predatory Journal

    My “colleagues” and I at the fictitious Arthur Vandelay Urological Research Institute were surprised to find our bogus “uromycitisis” case report swiftly accepted, with only minor revisions requested.

  2. Consilience, Episode 3: Cancer, Obscured
  3. March for Science: Dispatches from Washington, DC
  4. Record-Setting Corn Grows 45 Feet Tall
AAAS